ReleaseWire Connect

The market for Wound Dressing Market was valued at a staggering 10 US$ billions in the year 2017 and was expected to grow at a double-digit CAGR in the forecast period of 2019 to the year 2030.

The worldwide sample preparation market is assessed to be over US$ 5.5 Bn in 2017. It is foreseen to develop at a noteworthy digit CAGR from 2019 to 2030.

Orthobiologics Market was valued at over US$ 5.5 Bn. in 2017 and is expected to grow at a considerable CAGR during the forecasted period (2019-2030)

The market for Epigenetics was valued at a staggering 800 US$ millions in the year 2017 and was expected to grow at a double-digit CAGR in the forecast period of 2019 to the year 2030.

Some of the major players operating in the global NGS market are Agilent Technologies, 10x Genomics, Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company, Eurofins Scientific, Pacific Biosciences of California, Inc., BGI, Illumina, Inc., F. Hoffmann-La Roche AG, among others.

The report, ‘Hemostatic agents market’ fundamentally discovers insights that enable stakeholders, business owners and field marketing executives to make effective investment decisions driven by facts – rather than guesswork.

Cosmetic lasers market is estimated to be over US$ 1,500 Mn in 2018. It is anticipated to grow at a double digit CAGR from 2019 to 2030.

For stakeholders, field marketing executives and product owners planning to maintain a competitive edge the market assessment report brings to light essential impression about the growth rate, share and size of the industry during the estimated period.

Cranial implants market was estimated to be over US$ 800 Mn in 2018. It is anticipated to grow at a substantial CAGR from 2019 to 2030.

The global hyperpigmentation disorders treatment market is segmented by disease indication, treatment type, end-user, and region. The segment of disease indication can be segmented into melasma, post-inflammatory hyperpigmentation, solar, and other indications. Melasma segment within the disease indication segment is constituted a substantial share in 2018; this can be credited to the increasing incidences of this condition as compared to other indications.